Monoclonal Gammopathy of Undetermined Significance
NCI Definition: A plasma cell disorder in which an abnormal amount of a single immunoglobulin is present in the serum. Up to 25% of cases of monoclonal gammopathy of undetermined significance (MGUS) progress to a B-cell malignancy or myeloma. MGUS may occur in conjunction with various carcinomas, chronic inflammatory and infectious conditions, and other diseases. 
There is 1 clinical trial for monoclonal gammopathy of undetermined significance, of which 1 is open and 0 are completed or closed. Of the trial that contains monoclonal gammopathy of undetermined significance as an inclusion criterion, 1 is no phase specified (1 open).
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.